Randomized, Double-Blind Study Of The Morphine-Sparing Efficacy And Safety Of Parecoxib Sodium 40 Mg IV Followed By 20 Mg IV Every 12 Hours In The Treatment Of Pain Following Radical Prostatectomy.

Trial Profile

Randomized, Double-Blind Study Of The Morphine-Sparing Efficacy And Safety Of Parecoxib Sodium 40 Mg IV Followed By 20 Mg IV Every 12 Hours In The Treatment Of Pain Following Radical Prostatectomy.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2011

At a glance

  • Drugs Morphine; Parecoxib
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Planned end date changed from 1 Jun 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov..
    • 10 Sep 2008 Actual start date changed from Nov 2006 to Jun 2009 as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top